Benign-appearing mammographic abnormalities in women aged 40-49

Breast Journal

Volumn 8, Issue 3, 2002, Pages 162-170

  Seltzer, Murray H ^a,b,e   Glassman, Jill R ^c,d  

^a UNIVERSITY OF MEDICINE AND DENTISTRY   (United States)

^b SAINT BARNABAS MEDICAL CENTER   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Intersystems Incorporated   (United States)

^e NONE   (United States)

Author keywords

Age; Breast biopsy; Breast cancer; Double reading; Mammogram; Screening

Indexed keywords

ADULT; AGE; BREAST BIOPSY; BREAST CANCER; BREAST DISEASE; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; RISK ASSESSMENT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANXIETY; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNNECESSARY PROCEDURES;

EID: 0036282992     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2002.08309.x     Document Type: Conference Paper

References (45)

1. Breast cancer screening
2. Breast cancer survival among women under age 50: Is mammography Detrimental?
3. Benefit of mammography screening in women ages 40-49 years
4. Follow-up after 11 years-update of mortality results in the Stockholm mammographic screening trial
5. Breast cancer survival rates with mammographic screening: Similar favorable survival rates for women younger and those older than 50 years
6. Survival of women ages 40-49 years with breast carcinoma according to method of detection
7. The benefits of mammography are not limited to women of ages older than 50 years
8. Screening for breast cancer: Practical considerations
9. Screening mammography beginning at age 40 years
10. Concerns about recommending routine screening mammograms for women aged 40-49 years
11. Neglected aspects of false positive findings of mammography in breast cancer screening: Analysis of false positive cases from the Stockholm trial
12. Positive predictive value of screening mammography by age and family history of breast cancer
13. Mammography: Positive predictive value and true-positive biopsy rate
14. Ten-year risk of false positive screening mammograms and clinical breast examinations
15. Benefit and harm associated with screening for breast cancer
16. Screening mammography behavior after a false positive mammogram
17. The abnormal mammogram in women with clinically normal breasts
18. Clinical outcome of doubtful mammographic findings
19. The impact of mammography in 1096 consecutive patients with breast cancer, 1979-93: Equal value for patients younger and older than age 50 years
20. Nonpalpable lesions detected with mammography: Review of 512 consecutive cases
21. Categorizing a prognostic variable: Review of methods, code for easy implementation and applications to decision-making about cancer treatments
22. Breast biopsy rate and positivity in Rhode Island
23. The problems of benign/malignant ratio
24. Risk-based recommendations for mammographic screening for women in their forties
25. Nonpalpable, circumscribed, noncalcified solid breast masses: Likelihood of malignancy based on lesion size and age of patient
26. Periodic mammographic follow-up of probably benign lesions: Results in 3184 consecutive cases
27. Nonpalpable, probably benign lesions: Role of follow-up mammography
28. Xeroradiography of the breast: Overview of 21,057 consecutive cases
29. Mammographic follow-up of low-suspicions lesions: Compliance rate and diagnostic yield
30. Positive predictive value of breast biopsy performed as a result of mammography: There is no abrupt change at age 50 years
31. Efficacy of screening mammography for women in their forties
32. Neglected aspects of false positive findings of mammography in breast cancer screening: Analysis of false positive cases from the Stockholm trial
33. Compliance with mammography screening guidelines: 1995 mammography attitudes and usage study report
34. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age
35. Preoperative prediction of open breast biopsy results
36. Breast screening in women aged 40-49 years
37. Positive predictive value of the breast imaging reporting and data system
38. Variability in radiologists' interpretations of mammograms
39. Effect of human variability on independent double reading in screening mammography
40. Comparison of radiographer/radiologist double film reading in breast cancer screening
41. Opinions about mammographic double reading
42. Breast cancer. Prediction with artificial neural network based on BI-RADS standardized lexicon